Combination therapy with nirmatrelvir and molnupiravir improves the survival of SARS-CoV-2 infected miceJu Hwan Jeong, Min‐Suk Song, Jang‐Hoon Choi et al.|Antiviral Research|2022Cited by 82
Combination therapy with nirmatrelvir and molnupiravir improves the survival of SARS-CoV-2 infected miceJu Hwan Jeong, Min‐Suk Song, Sol Oh et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 10
Evaluating Z-FA-FMK, a host cathepsin L protease inhibitor, as a potent and broad-spectrum antiviral therapy against SARS-CoV-2 and related coronavirusesJu Hwan Jeong, Min‐Suk Song, Jang‐Hoon Choi et al.|Antiviral Research|2023Cited by 7
Mammalian adaptation risk in HPAI H5N8: a comprehensive model bridging experimental data with mathematical insightsSantosh Chokkakula, Min‐Suk Song, Eung‐Gook Kim et al.|Emerging Microbes & Infections|2024Cited by 4
Evaluation of the Antiviral Efficacy of Subcutaneous Nafamostat Formulated with Glycyrrhizic Acid against SARS-CoV-2 in a Murine ModelJu Hwan Jeong, Min‐Suk Song, Eung‐Gook Kim et al.|International Journal of Molecular Sciences|2023Cited by 2